NCT03943082 2021-11-16
Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
University of California, San Francisco
Phase NA Terminated
Clinical Trials
6 trialsNCT02730884 2020-08-07
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02225574 2020-02-12
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01875237 2019-07-16
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT02473523 2017-03-08
Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia
St. Jude Children's Research Hospital
Phase NA Terminated
NCT00504985 2012-08-01
Fatigue in Emergency Center Patients
M.D. Anderson Cancer Center
Terminated